Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Prenat Diagn ; 35(11): 1085-92, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26179089

RESUMO

OBJECTIVE: To review prevalence, management and prognostic factors of pulmonary stenosis (PS) in monochorionic diamniotic (MCDA) pregnancies complicated by twin-to-twin transfusion syndrome (TTTS). METHODS: Retrospective study over the last 10 years in a single referral center. We reviewed fetal echocardiography data of all MC twin cases with diagnosis of isolated PS. We assessed fetoscopy characteristics of those that underwent laser coagulation. We collected data regarding perinatal outcome, neonatal echocardiography and cardiac management. RESULTS: We found 24 cases of isolated PS among 2091 MCDA pregnancies. Among 1052 complicated MCDA that underwent fetal laser surgery, 22 (2.09%) developed PS of which 20 were diagnosed prenatally. Two cases were diagnosed in uncomplicated MCDA pregnancies (0.2%). Four of 22 (18.18%) cases with TTTS showed in utero regression after laser treatment. Thirteen newborns (65%) required valvular dilatation. Peak systolic velocities in the pulmonary artery trunk (PSV-PA) at diagnosis and the interval between the diagnosis of TTTS and that of PS were significantly different (p < 0.001 and p = 0.05 respectively) between PS requiring cardiac intervention and those who did not. CONCLUSION: An elevated PSV-PA at the time of PS diagnosis and a short time-interval between fetoscopic laser surgery and PS diagnosis are predictive of the need for interventional treatment after birth.


Assuntos
Âmnio/diagnóstico por imagem , Córion/diagnóstico por imagem , Transfusão Feto-Fetal/epidemiologia , Gravidez de Gêmeos , Artéria Pulmonar/diagnóstico por imagem , Estenose da Valva Pulmonar/epidemiologia , Gêmeos Monozigóticos , Gerenciamento Clínico , Ecocardiografia , Feminino , Fetoscopia , Humanos , Recém-Nascido , Fotocoagulação a Laser , Terapia a Laser , Gravidez , Prevalência , Prognóstico , Estenose da Valva Pulmonar/diagnóstico por imagem , Estenose da Valva Pulmonar/terapia , Estudos Retrospectivos , Resultado do Tratamento , Ultrassonografia Pré-Natal
3.
J Perinatol ; 38(1): 31-34, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29048403

RESUMO

OBJECTIVES: Congenital chylothorax is a rare disease and prognostic factors are key element in properly informing parents. This study aimed at determining the prenatal factors associated with neonatal survival in a cohort of liveborn infants with congenital chylothorax. STUDY DESIGN: Observational monocentric cohort study including all liveborn neonates consecutively admitted for congenital chylothorax. RESULTS: Neonatal mortality was 32% (16/50). Prematurity (or birth weight), persistence of hydrops at birth and the absence of thoracoamniotic shunt procedure were significantly associated with mortality, whereas prenatal diagnosis of pleural effusion, side of pleural effusion, hydrops fetalis and amniodrainage were not. In case of prenatal diagnosis of hydrops fetalis, the reversal in utero of hydrops fetalis was significantly associated with survival (P=0.001). In case of thoracoamniotic shunting, the interval between thoracoamniotic shunting intervention and delivery was significantly longer for patients who survived (P=0.03). CONCLUSIONS: Thoracoamniotic shunting and reversal of hydrops significantly improves survival, whereas prematurity worsened outcome of liveborn infants with congenital chylothorax. Our data also suggest that the interval between thoracoamniotic shunting and birth appears to be crucial; the longer the interval, the more likely is the reversal of antenatal hydrops and neonatal survival.


Assuntos
Quilotórax/congênito , Hidropisia Fetal/cirurgia , Derrame Pleural/cirurgia , Adolescente , Adulto , Líquido Amniótico , Quilotórax/mortalidade , Estudos de Coortes , Drenagem/métodos , Feminino , Morte Fetal , França , Idade Gestacional , Humanos , Hidropisia Fetal/diagnóstico por imagem , Hidropisia Fetal/mortalidade , Recém-Nascido , Recém-Nascido Prematuro , Modelos Logísticos , Derrame Pleural/diagnóstico por imagem , Derrame Pleural/mortalidade , Gravidez , Resultado da Gravidez , Diagnóstico Pré-Natal , Taxa de Sobrevida , Toracostomia/métodos , Ultrassonografia Pré-Natal , Adulto Jovem
4.
Arch Pediatr ; 24(2): 107-111, 2017 Feb.
Artigo em Francês | MEDLINE | ID: mdl-28012639

RESUMO

BACKGROUND: To reach nutritional standards, human milk has to have 2g/dL of protein. In 2013, Lafeber stated that when human milk is fortified up to 2g/dL, it may increase its osmolality up to 500 mOsm/kg. He also warned that care must be taken when adding a drug or vitamins to human milk. AIM: We studied, for the first time, the impact of adding multivitamins (ADEC) on human fortified milk osmolality. METHOD: The osmolality of 36 pasteurized, fortified human milk samples was measured. The amount of milk required as a solvent to maintain osmolality below 500 mOsm/kg was then determined. RESULTS: The osmolality of 2mL of fortified human milk reached up to 750 mOsm/kg when the multivitamins ADEC was added. The osmolality decreased proportionately as the solution was diluted and if vitamins are added in two half-doses each time. It is only with 20mL of milk that the osmolality lowers to its initial rate of 430 mOsm/kg. The stronger the milk's fortification is, the greater impact it has on the milk's osmolality. CONCLUSION: New nutritional recommendations for premature infants are needed. In the meantime, when the fortified milk intake is under 20mL, it is preferable to extend parenteral intakes with fat-soluble vitamins or reduce doses of vitamins in milk. Also, we should use enriched human milk as a fortifier and be cautious with indiscriminate fortification or when adding drugs and electrolyte solutions.


Assuntos
Alimentos Fortificados , Fidelidade a Diretrizes , Doenças do Prematuro/terapia , Leite Humano , Vitaminas/administração & dosagem , Ácido Ascórbico/administração & dosagem , Proteínas Alimentares/administração & dosagem , Humanos , Concentração Osmolar , Vitamina A/administração & dosagem , Vitamina D/administração & dosagem , Vitamina E/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA